Literature DB >> 12105993

Radiation effects on breast cancer risk: a pooled analysis of eight cohorts.

Dale L Preston1, Anders Mattsson, Erik Holmberg, Roy Shore, Nancy G Hildreth, John D Boice.   

Abstract

Breast cancer incidence rates after radiation exposure in eight large cohorts are described and compared. The nature of the exposures varies appreciably, ranging from a single or a small number of high-dose-rate exposures (Japanese atomic bomb survivors, U.S. acute post-partum mastitis patients, Swedish benign breast disease patients, and U.S. infants with thymic enlargement) to highly fractionated high-dose-rate exposures (two U.S. tuberculosis cohorts) and protracted low-dose-rate exposure (two Swedish skin hemangioma cohorts). There were 1,502 breast cancers among 77,527 women (about 35,000 of whom were exposed) with 1.8 million woman-years of follow-up. The excess risk depends linearly on dose with a downturn at high doses. No simple unified summary model adequately describes the excess risks in all groups. Excess risks for the thymus, tuberculosis, and atomic bomb survivor cohorts have similar temporal patterns, depending on attained age for relative risk models and on both attained age and age at exposure for excess rate models. Excess rates were similar in these cohorts, whereas, related in part to the low breast cancer background rates for Japanese women, the excess relative risk per unit dose in the bomb survivors was four times that in the tuberculosis or thymus cohorts. Excess rates were higher for the mastitis and benign breast disease cohorts. The hemangioma cohorts showed lower excess risks suggesting ameliorating dose-rate effects for protracted low-dose-rate exposures. For comparable ages at exposure (approximately 0.5 years), the excess risk in the hemangioma cohorts was about one-seventh that in the thymus cohort, whose members received acute high-dose-rate exposures. The results support the linearity of the radiation dose response for breast cancer, highlight the importance of age and age at exposure on the risks, and suggest a similarity in risks for acute and fractionated high-dose-rate exposures with much smaller effects from low-dose-rate protracted exposures. There is also a suggestion that women with some benign breast conditions may be at elevated risk of radiation-associated breast cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12105993     DOI: 10.1667/0033-7587(2002)158[0220:reobcr]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  146 in total

Review 1.  Hormesis, an update of the present position.

Authors:  Lennart Johansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-26       Impact factor: 9.236

2.  Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.

Authors:  Kathryn P Lowry; Janie M Lee; Chung Y Kong; Pamela M McMahon; Michael E Gilmore; Jessica E Cott Chubiz; Etta D Pisano; Constantine Gatsonis; Paula D Ryan; Elissa M Ozanne; G Scott Gazelle
Journal:  Cancer       Date:  2011-09-20       Impact factor: 6.860

3.  Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958-1998.

Authors:  J C Kaiser; P Jacob; R Meckbach; H M Cullings
Journal:  Radiat Environ Biophys       Date:  2011-09-23       Impact factor: 1.925

Review 4.  Effects of radiation exposure from cardiac imaging: how good are the data?

Authors:  Andrew J Einstein
Journal:  J Am Coll Cardiol       Date:  2012-02-07       Impact factor: 24.094

5.  Dose-rate effects of protons on in vivo activation of nuclear factor-kappa B and cytokines in mouse bone marrow cells.

Authors:  Kanokporn Noy Rithidech; Paiboon Reungpatthanaphong; Louise Honikel; Adam Rusek; Sanford R Simon
Journal:  Radiat Environ Biophys       Date:  2010-05-28       Impact factor: 1.925

6.  Breast cancer risk from different mammography screening practices.

Authors:  Harmen Bijwaard; Alina Brenner; Fieke Dekkers; Teun van Dillen; Charles E Land; John D Boice
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

7.  Organ-based tube current modulation in a clinical context: Dose reduction may be largely overestimated in breast tissue.

Authors:  André Euler; Zsolt Szucs-Farkas; Anna L Falkowski; Nadine Kawel-Böhm; Luigia D'Errico; Sebastién Kopp; Jens Bremerich; Tilo Niemann
Journal:  Eur Radiol       Date:  2015-11-12       Impact factor: 5.315

8.  Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis.

Authors:  Amy Berrington de González; Kwang Pyo Kim; Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; Rebecca Smith-Bindman; Judy Yee; Karen M Kuntz; Marjolein van Ballegooijen; Ann G Zauber; Christine D Berg
Journal:  AJR Am J Roentgenol       Date:  2011-04       Impact factor: 3.959

Review 9.  New biological insights on the link between radiation exposure and breast cancer risk.

Authors:  Mary Helen Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-01-17       Impact factor: 2.673

10.  Projected cancer risks from computed tomographic scans performed in the United States in 2007.

Authors:  Amy Berrington de González; Mahadevappa Mahesh; Kwang-Pyo Kim; Mythreyi Bhargavan; Rebecca Lewis; Fred Mettler; Charles Land
Journal:  Arch Intern Med       Date:  2009-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.